These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3949507)

  • 1. [Treatment of vitiligo].
    Frenk E
    Hautarzt; 1986 Jan; 37(1):1-5. PubMed ID: 3949507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 0.05% clobetasol propionate cream and topical Puvasol in childhood vitiligo.
    Khalid M; Mujtaba G; Haroon TS
    Int J Dermatol; 1995 Mar; 34(3):203-5. PubMed ID: 7751099
    [No Abstract]   [Full Text] [Related]  

  • 3. Vitiligo: current medical and scientific understanding.
    Boissy RE; Nordlund JJ
    G Ital Dermatol Venereol; 2011 Feb; 146(1):69-75. PubMed ID: 21317859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral and topical L-phenylalanine, clobetasol propionate, and UVA/sunlight--a new study for the treatment of vitiligo.
    Camacho F; Mazuecos J
    J Drugs Dermatol; 2002 Sep; 1(2):127-31. PubMed ID: 12847735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid repigmentation after depigmentation therapy: vitiligo treated with monobenzyl ether of hydroquinone.
    Oakley AM
    Australas J Dermatol; 1996 May; 37(2):96-8. PubMed ID: 8687336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcipotriene and corticosteroid combination therapy for vitiligo.
    Travis LB; Silverberg NB
    Pediatr Dermatol; 2004; 21(4):495-8. PubMed ID: 15283800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized vitiligo successfully treated with cream-psoralen + ultraviolet A.
    Kreuter A; Gambichler T; Avermaete A; Jansen T; Altmeyer P; von Kobyletzki G
    J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):357-8. PubMed ID: 11730053
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose prednisolone and psoralen ultraviolet A combination therapy in 36 patients with vitiligo.
    Lee Y; Seo YJ; Lee JH; Park JK
    Clin Exp Dermatol; 2007 Sep; 32(5):499-501. PubMed ID: 17608760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discussion of a case of vitiligo.
    Lerner MR; Fitzpatrick TB; Halder RM; Hawk JL
    Photodermatol Photoimmunol Photomed; 1999 Feb; 15(1):41-4. PubMed ID: 9990671
    [No Abstract]   [Full Text] [Related]  

  • 11. The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients.
    Radmanesh M; Saedi K
    J Dermatolog Treat; 2006; 17(3):151-3. PubMed ID: 16854754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.
    Lepe V; Moncada B; Castanedo-Cazares JP; Torres-Alvarez MB; Ortiz CA; Torres-Rubalcava AB
    Arch Dermatol; 2003 May; 139(5):581-5. PubMed ID: 12756094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatitis produced by applications of monobenzone in patients with active vitiligo.
    Nordlund JJ; Forget B; Kirkwood J; Lerner AB
    Arch Dermatol; 1985 Sep; 121(9):1141-4. PubMed ID: 2931053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
    Parsad D; Kanwar AJ; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind trial of 0-05% clobetasol proprionate in the treatment of vitiligo.
    Clayton R
    Br J Dermatol; 1977 Jan; 96(1):71-3. PubMed ID: 320996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic cutaneous effects of long-term psoralen and ultraviolet radiation therapy in patients with vitiligo.
    Harrist TJ; Pathak MA; Mosher DB; Fitzpatrick TB
    Natl Cancer Inst Monogr; 1984 Dec; 66():191-6. PubMed ID: 6531028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcipotriol and PUVA as treatment for vitiligo.
    Cherif F; Azaiz MI; Ben Hamida A; Ben O; Dhari A
    Dermatol Online J; 2003 Dec; 9(5):4. PubMed ID: 14996377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of segmental vitiligo to 0.05% clobetasol propionate cream.
    Khalid M; Mujtaba G
    Int J Dermatol; 1998 Sep; 37(9):705-8. PubMed ID: 9762827
    [No Abstract]   [Full Text] [Related]  

  • 19. Autografting and PUVA. A combination therapy for vitiligo.
    Skouge JW; Morison WL; Diwan RV; Rotter S
    J Dermatol Surg Oncol; 1992 May; 18(5):357-60. PubMed ID: 1607458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo.
    Coskun B; Saral Y; Turgut D
    Eur J Dermatol; 2005; 15(2):88-91. PubMed ID: 15757818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.